DTaP-IPV vaccine
DPT-IPV vaccine in Japan
Combination of
DTaP vaccineVaccine
Inactivated poliovirus vaccineVaccine
Clinical data
Trade namesKinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
Other namesdiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
AHFS/Drugs.comKinrix Quadracel
Pregnancy
category
  • AU: A
Routes of
administration
Intramuscular injection
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number

DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1][2]

It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1]

Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[3] and Quadracel from Sanofi Pasteur.[4]

Repevax is available in the UK.[5][6]

Within Japan, the formulation is called 四種混合(shishukongou - "mixture of 4"). Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available from Mitsubishi Tanabe Pharma named テトラビック ('Tetrabic').[7][8] A previous product by Takeda Pharmaceutical Company has been withdrawn by the company.[9]

References

  1. 1 2 3 "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
  2. Syed YY (October 2019). "DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination". Paediatric Drugs. 21 (5): 397–408. doi:10.1007/s40272-019-00353-7. PMC 6794236. PMID 31444785.
  3. "Kinrix". US Food and Drug Administration. Retrieved 15 July 2018.
  4. "Quadracel". US Food and Drug Administration. Retrieved 15 July 2018.
  5. "Repevax, suspension for injection, in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)". www.medicines.org.uk. Retrieved 31 December 2020.
  6. "14. Vaccines". British National Formulary (BNF) (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 1381. ISBN 978-0-85711-369-6.
  7. "医療用医薬品 : テトラビック (テトラビック皮下注シリンジ)". www.kegg.jp. Retrieved 2021-02-27.
  8. "医療用医薬品 : クアトロバック (クアトロバック皮下注シリンジ)". www.kegg.jp. Retrieved 2021-02-27.
  9. "【武田薬品】4種混合ワクチンの開発中止‐ノロウイルスなどに資源投入|薬事日報ウェブサイト". 9 February 2015. Retrieved 2021-02-27.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.